NYTIMES  |  Health

’Shrooms Lead the Pack in Psychedelic Medicine, but Rollout Is Bumpy

蘑菇在迷幻药物医疗中领先,但推广进展坎坷

Dr. Bonny Koeber prepared a therapy room with sage before a patient arrived from New York for psilocybin therapy at Satya Therapeutics in Ashland, Ore.

Dr. Bonny Koeber prepared a therapy room with sage before a patient arrived from New York for psilocybin therapy at Satya Therapeutics in Ashland, Ore.

2026-01-13  1914  晦涩
字体大小

0:00
0:00

此音频仅限会员使用成为会员

The news is among the first concrete signs that the Trump administration is recognizing psychedelic medicine as a potential therapy tool. The moves have injected a fresh dose of optimism into a nascent field, which was rattled by the F.D.A.’s rejection in 2024 of MDMA-assisted therapy, the first psychedelic to reach a formal review by federal regulators.

请登录后继续阅读完整文章

还没有账号?立即注册

成为会员后您将享受无限制的阅读体验,并可使用更多功能,了解更多


免责声明:本文来自网络公开资料,仅供学习交流,其观点和倾向不代表本站立场。